HMGB12 Antibody

What are the structural and functional differences between HMGB1 and HMGB2 proteins?

HMGB1 and HMGB2 belong to a family of highly conserved proteins containing HMG box domains. Both proteins share significant sequence homology, with human and murine HMGB1 and HMGB2 showing 99% and 97% sequence identity respectively between species . While structurally similar, they differ in expression patterns: HMGB1 is widely expressed and highly abundant across tissues, whereas HMGB2 expression is widespread during embryonic development but becomes restricted to lymphoid organs and testis in adult organisms .

Both proteins contain two HMG box domains and a C-terminal acidic domain . These structural similarities contribute to challenges in developing antibodies with complete specificity for either protein. Functionally, both are involved in DNA-related processes, but their roles can be distinct in certain cellular contexts. For instance, in neutrophils, HMGB1 has been found predominantly in the cytosol distributed in puncta, while HMGB2 remains in the nucleus .

What applications are validated for HMGB1 and HMGB2 antibodies?

HMGB1 and HMGB2 antibodies have been validated for multiple research applications as detailed below:

For HMGB2 Antibody (14597-1-AP), published applications include knockout/knockdown validation and immunofluorescence studies, with citations in at least 13 publications for Western blot applications and 3 publications for immunofluorescence .

How can I optimize antibody dilutions for different experimental applications?

Optimal antibody dilutions vary by application and specific antibody. Based on the data from commercial antibodies, recommended dilutions are:

For HMGB2 Antibody (15605-1-AP):

• Western Blot: 1:500-1:2400

• Immunohistochemistry: 1:150-1:600

For HMGB2 Antibody (14597-1-AP):

• Western Blot: 1:500-1:3000

• Immunoprecipitation: 0.5-4.0 μg for 1.0-3.0 mg of total protein lysate

• Immunohistochemistry: 1:50-1:500

• Immunofluorescence: 1:200-1:800

For HMGB1 Antibody (19N12A1):

• Western Blot: 1-3 μg/mL

• Simple Western: 1:100

It is strongly recommended to titrate these antibodies in your specific experimental system to determine optimal working conditions. Sensitivity can vary based on sample type, detection method, and experimental conditions. For critical experiments, performing a dilution series is advisable to identify the optimal signal-to-noise ratio.

What protein extraction and preparation methods are recommended for HMGB detection?

When preparing samples for HMGB protein detection, consider the following methodological aspects:

• Redox Conditions: Reducing conditions typically provide better detection for HMGB proteins. Studies have shown that antibodies like Ab92310 displayed higher affinity for reduced forms of HMGB1 and struggled to detect the non-reduced form .

• Molecular Weight Considerations: HMGB1 and HMGB2 have calculated molecular weights of approximately 24 kDa, but observed molecular weights vary:

  • HMGB2 (15605-1-AP): 24-28 kDa

  • HMGB2 (14597-1-AP): 33-35 kDa

  • HMGB1 in Simple Western: 35 kDa

• Sample Buffer: For Western blotting, standard SDS-PAGE sample buffers with reducing agents (beta-mercaptoethanol or DTT) are recommended based on the observation that antibody detection is enhanced under reducing conditions .

• Sample Handling: For long-term storage, store samples at -20°C and avoid repeated freeze-thaw cycles to preserve protein integrity.

How can I address cross-reactivity issues between HMGB1 and HMGB2 antibodies?

Cross-reactivity between HMGB1 and HMGB2 antibodies is a significant concern due to high sequence homology. Research has identified that several commercially available anti-HMGB1 antibodies cross-react with HMGB2, specifically:

• MAB1690 and 6893 antibodies readily detected both HMGB1 and HMGB2

• Ab92310 weakly detected HMGB2 in addition to HMGB1

To address cross-reactivity issues:

• Validate with Recombinant Proteins: Test antibodies against both recombinant HMGB1 and HMGB2 proteins to assess potential cross-reactivity.

• Use Knockout/Knockdown Controls: Utilize HMGB1-/- and HMGB2-/- cell lines or knockdown models when available. For example, MEF HMGB1-/- and HMGB2-/- cell lines have been used to validate antibody specificity .

• Antibody Selection: Choose antibodies that have been specifically validated for lack of cross-reactivity. The HMGB1 antibody #3935 demonstrated good specificity in MEF knockout models .

• Orthogonal Validation: Confirm findings using multiple antibodies targeting different epitopes or using orthogonal techniques like mass spectrometry.

What methods can validate the specificity of HMGB1/HMGB2 antibodies in research applications?

To ensure reliable experimental results, validate antibody specificity through these approaches:

• Western Blot with Knockout/Knockdown Controls: The most stringent validation method uses genetic knockout models. Studies have demonstrated specificity using MEF HMGB1-/- and HMGB2-/- cell lines, where specific antibodies detected single bands at the expected molecular weight that were absent in the respective knockout cells .

• Immunoprecipitation Followed by Mass Spectrometry: This approach can confirm pulled-down proteins are indeed the target of interest.

• Cellular Localization Patterns: Different cellular distributions of HMGB1 and HMGB2 can help confirm specificity. In neutrophils, HMGB1 shows predominantly cytosolic punctate distribution while HMGB2 remains nuclear .

• Epitope Mapping: Understanding the specific epitope region recognized by an antibody can help predict potential cross-reactivity. For example, the HMGB1 antibody 19N12A1 recognizes both the B box domain (amino acids 88-162) and full-length HMGB1 protein .

How do HMGB1 and HMGB2 proteins interact with other molecules in cancer research models?

Research on epithelial ovarian cancers (EOC) has identified several protein interactions for both HMGB1 and HMGB2:

HMGB1 Interactions in EOC Models:

• SKOV-3 cell line: MALAT1 (lncRNA), AKIP1, KRT7, ATF71P, UHRF2, WDR60

• Ovarian tumor tissue: C1QA, DAG1, RPL29, RSF1, TGM2

HMGB2 Interactions in EOC Models:

• SKOV-3 cell line: BCCIP, COMMD1, NOP53, MIEN1, ROCK1, U2AF1, ZNF668

• Ovarian tumor tissue: COMMD1, MIEN1, PCBP1, TBC1D25, ZFR, ZNF428

Of particular interest:

• ROCK1 (interacting with HMGB2): A Rho-associated protein kinase that regulates actin cytoskeleton and cell polarity

• U2AF1 (interacting with HMGB2): A splicing factor involved in 3′-splice site selection

These interactions have been validated in different cell models. For example, HMGB2 interactions with MIEN1 and NOP53 were confirmed by co-immunoprecipitation in both SKOV-3 and PEO1 cell lines, with NOP53 co-immunoprecipitation being more efficient in SKOV-3 than in PEO1 cells .

What are the considerations for detecting different redox forms of HMGB proteins?

The redox state of HMGB proteins affects both their function and detection by antibodies. Key considerations include:

• Antibody Preference for Redox Forms: Some antibodies show differential affinities for reduced versus oxidized forms. For example, Ab92310 readily detected reduced HMGB1 but was particularly poor at detecting non-reduced HMGB1 .

• Electrophoretic Mobility: Non-reduced HMGB1 runs slightly faster in SDS-PAGE than reduced HMGB1, suggesting that the single disulfide bond influences the protein's globular structure .

• Preservation of Redox State: If analyzing specific redox forms is critical, sample preparation should carefully maintain the native redox state through appropriate buffers and handling conditions.

• Functional Implications: Different redox forms may have distinct biological activities, particularly in inflammatory and immune contexts. Therefore, the ability to specifically detect these forms can be crucial for functional studies.

What are common issues in immunohistochemistry with HMGB antibodies and their solutions?

When performing immunohistochemistry with HMGB antibodies, researchers should consider:

• Antigen Retrieval Methods: Different HMGB antibodies have specific requirements:

  • HMGB2 Antibody (15605-1-AP): Suggested antigen retrieval with TE buffer pH 9.0; alternatively, citrate buffer pH 6.0

  • HMGB2 Antibody (14597-1-AP): Suggested antigen retrieval with TE buffer pH 9.0; alternatively, citrate buffer pH 6.0

• Tissue-Specific Optimization: HMGB2 antibodies have been validated on specific tissues:

  • HMGB2 Antibody (15605-1-AP): Validated on human normal colon and human lymphoma tissue

  • HMGB2 Antibody (14597-1-AP): Validated on mouse brain tissue

• Dilution Range: Use a wide dilution range in initial optimization:

  • HMGB2 Antibody (15605-1-AP): 1:150-1:600

  • HMGB2 Antibody (14597-1-AP): 1:50-1:500

• Background Reduction: If background staining is observed, consider:

  • Including additional blocking steps with normal serum

  • Using more dilute antibody solutions

  • Including 0.1-0.3% Triton X-100 in antibody diluent to improve penetration

  • Reducing incubation times

How can I differentiate between HMGB1 and HMGB2 in co-expression studies?

When studying samples where both HMGB1 and HMGB2 are co-expressed, consider these approaches:

• Subcellular Localization Analysis: In certain cell types like neutrophils, HMGB1 and HMGB2 show distinct localization patterns (HMGB1 is cytosolic in puncta while HMGB2 remains nuclear), which can be exploited for differentiation using confocal microscopy .

• Sequential Immunoprecipitation: Perform sequential immunoprecipitation with validated specific antibodies to separate and identify each protein.

• Western Blot with Highly Specific Antibodies: Use antibodies that have been validated in knockout models, such as anti-HMGB1 3935 and anti-HMGB2 Ab124670, which have demonstrated specificity in MEF knockout models .

• Double Immunofluorescence: Employ differently labeled secondary antibodies against primary antibodies from different host species (e.g., rabbit anti-HMGB1 and mouse anti-HMGB2).

• RNA-based Methods: Supplement protein detection with RNA-based methods like RNA-FISH or qPCR that can distinguish between the two transcripts.

What are the optimal storage conditions for maintaining HMGB antibody reactivity?

Proper storage is crucial for maintaining antibody performance over time. Based on manufacturer recommendations:

For HMGB2 Antibody (15605-1-AP) and (14597-1-AP):

• Store at -20°C

• Stable for one year after shipment

• Aliquoting is unnecessary for -20°C storage

• Provided in PBS with 0.02% sodium azide and 50% glycerol pH 7.3

• 20μl sizes contain 0.1% BSA

For HMGB1 Antibody (19N12A1):

• Store at 4°C for short term

• Aliquot and store at -20°C for long term

• Avoid freeze-thaw cycles

• Provided in PBS with 0.05% sodium azide

When working with these antibodies, it is advisable to prepare small working aliquots for repeated use to minimize freeze-thaw cycles that can degrade antibody performance.